ID   sVero p66
SY   sVero; Vero E6 AGS
DR   Wikidata; Q54971007
RX   Patent=US20090203112;
RX   PubMed=19559123;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2791.
CC   Characteristics: Adapted to suspension growth in serum-free media.
CC   Doubling time: 24 hours (Patent=US20090203112).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 8
RX   Patent=US20090203112;
RA   Daelli M.G., Forno G., Paillet P., Etcheverrigaray M., Kratje R.;
RT   "Vero cell line which is adapted to grow in suspension.";
RL   Patent number US20090203112, 13-Aug-2009.
RX   PubMed=19559123; DOI=10.1016/j.vaccine.2009.06.020;
RA   Paillet C., Forno G., Kratje R., Etcheverrigaray M.;
RT   "Suspension-Vero cell cultures as a platform for viral vaccine
RT   production.";
RL   Vaccine 27:6464-6467(2009).